Category: Blog

On August 20, Mr Jagat Prakash Nadda, Hon’ble Minister of Health and Family Welfare, Government of India, announced at a function in Chennai that the government has decided to launch Mycobacterium indicus pranii (MIP), an exclusive vaccine for leprosy, developed in India, on a pilot basis in five districts of Bihar and Gujarat within a few weeks. Dr Soumya Swaminathan, director general of Indian Council of Medical Research, said MIP has the potential to bring down new cases of leprosy by 60% in three years.

I reached my desk after the morning devotion at the hospital chapel on that sunny June morning. I felt energised. As a patient counsellor at TLM

Hospital, Barabanki, I expected a lot of patients that day. Suddenly, eighteen-year-old Sarvesh appeared in front of me.

Dipnarayan has achieved financial security withTLMTI’s Community Based Rehabilitation Project. Working as a labourer for the Food Corporation of India in Assam, Dipnarayan had started to notice the tell-tale signs of Leprosy on his foot. He became weak, lost sensation in his foot and began dragging it along the ground.

Indian Railways’ Toofan Express chugged in to New Delhi Railway Station on a pleasant afternoon in August, 1983. 18-year-old Luska Karmakar got ready to alight from the train. He had many apprehensions about the big city of Delhi.

The fact that fear is only in your head, is proved rightly by Birendra Kumar, 35, who went through his ulcer treatment of his right foot in May 2014, at TLM Naini Hospital. In 2005, he was injured with a stone in Mumbai. He spent over Rs 2 lakhs on his treatment, but no doctor could diagnose or offer suitable treatment.